Babcock & Wilcox Enterprises, Inc.·4

May 19, 4:23 PM ET

Boness Naomi Louise 4

4 · Babcock & Wilcox Enterprises, Inc. · Filed May 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Babcock & Wilcox (BW) Director Naomi Boness Exercises Options, Sells Shares

What Happened

  • Naomi Louise Boness, a director of Babcock & Wilcox Enterprises (BW), exercised derivative awards and completed related settlements on May 15, 2026. She exercised/converted derivatives to acquire 85,000 shares at $21.22 per share (total value ≈ $1,803,700). On the same date 46,750 shares were disposed to the issuer at $21.22/share (≈ $992,035), and an award of 8,725 contingent shares was recorded (no cash value). The transactions include actions to satisfy tax/settlement obligations and involve derivative instruments rather than open-market purchases.

Key Details

  • Transaction date(s): May 15, 2026.
  • Main amounts/prices:
    • Exercise: 85,000 shares acquired @ $21.22 (≈ $1,803,700).
    • Disposition to issuer: 46,750 shares @ $21.22 (≈ $992,035) — used for settlement/tax.
    • Additional entries: 85,000 derivative shares shown as disposed at $0.00 (technical/derivative conversion) and a grant of 8,725 contingent shares @ $0.00.
  • Shares owned after transaction: not specified in the provided filing details.
  • Footnotes of note:
    • F1: BW settled a portion of vested restricted stock units in cash to facilitate tax payments (explains the disposition/withholding).
    • F2: The grant (8,725) represents a contingent right to receive one share each under the LTIP.
    • F3/F4: Vesting timing — some awards vest May 15, 2026 (or next Annual Meeting) and others May 15, 2027 (or next Annual Meeting).
  • Filing timeliness: Filed May 19, 2026 for a May 15, 2026 transaction — appears timely under standard Form 4 deadlines.

Context

  • This was an exercise/conversion of derivative securities (code M) with shares surrendered/settled to cover taxes or exercise costs (a common, routine outcome of option/RSU exercises). The net effect is acquisition via exercise plus internal settlement rather than an open-market buy or discretionary sale. These actions are administrative and don’t by themselves indicate the director’s broader market view.

Insider Transaction Report

Form 4
Period: 2026-05-15
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-15$21.22/sh+85,000$1,803,700189,530 total
  • Disposition to Issuer

    Common Stock

    [F1]
    2026-05-15$21.22/sh46,750$992,035142,780 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-05-1585,0000 total
    Common Stock (85,000 underlying)
  • Award

    Restricted Stock Units

    [F2][F4]
    2026-05-15+8,7258,725 total
    Common Stock (8,725 underlying)
Footnotes (4)
  • [F1]Represents the settlement in cash, pursuant to the applicable award terms, by BW of a portion of the restricted stock units that vested to facilitate tax payments by the reporting person.
  • [F2]Pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated 2021 Long-Term Incentive Plan and represents a contingent right to receive one share of common stock.
  • [F3]Vests May 15, 2026 or date of next Annual Meeting, whichever is earlier.
  • [F4]Vests May 15, 2027 or date of next Annual Meeting, whichever is earlier.
Signature
/s/ John J. Dziewisz, attorney-in-fact for Naomi Louise Boness|2026-05-19

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT